Aktivitäten
-
Thanks for joining the ride with us Chuan-Hsin Yin! This is what BiotechBikers is all about!
Thanks for joining the ride with us Chuan-Hsin Yin! This is what BiotechBikers is all about!
Beliebt bei Dominik Schumacher
-
🚴 And off they go! Unser „Miles for Smiles“-Team von #BMSgermany hat heute die europäische Ausgabe der diesjährigen „Country 2 Country 4…
🚴 And off they go! Unser „Miles for Smiles“-Team von #BMSgermany hat heute die europäische Ausgabe der diesjährigen „Country 2 Country 4…
Beliebt bei Dominik Schumacher
-
If you are in Boston, too.....let´s meet!
If you are in Boston, too.....let´s meet!
Beliebt bei Dominik Schumacher
Berufserfahrung
Ausbildung
Bescheinigungen und Zertifikate
Ehrenamt
-
Advisor
Schering Stiftung
–Heute 5 Jahre 8 Monate
Science and Technology
-
President
Rotaract Club Solingen-Neanderthal (Partner of Rotary)
– 1 Jahr 1 Monat
Social Services
-
President
Rotaract Club Solingen-Neanderthal (Partner of Rotary)
– 1 Jahr 1 Monat
Social Services
-
Member
Rotaract Solingen-Neanderthal (Partner of Rotary)
– 9 Jahre
Social Services
Veröffentlichungen
-
TuPPL: Tub-tag mediated C-terminal Protein-Protein-Ligation Using Complementary Click-Chemistry Handles
Organic & Biomolecular Chemistry
Another great example of the Tub-tag® technology for protein-protein ligation.
Abstract:
We introduce a chemoenzymatic strategy for straightforward in vitro generation of C-terminally linked fusion proteins. Tubulin tyrosine ligase is used for the incorporation of complementary click chemistry handles facilitating subsequent formation of functional bispecific antibody-fragments. This simple strategy may serve as central conjugation hub for a modular protein ligation platform. -
Cysteine‐selective phosphonamidate electrophiles for modular protein bioconjugations
Angewandte Chemie Int. Ed.
We describe a new technique in protein synthesis that extends the existing repertoire of methods for protein modification: A chemoselective reaction that induces reactivity for a subsequent bioconjugation. Hereby, an azide building block reacts first with an ethynylphosphonite via the Staudinger‐phosphonite reaction (SPhR) to an ethynylphosphonamidate. The resulting electron‐deficient triple bond subsequently undergoes a cysteine‐selective reaction with proteins or antibodies. We demonstrate…
We describe a new technique in protein synthesis that extends the existing repertoire of methods for protein modification: A chemoselective reaction that induces reactivity for a subsequent bioconjugation. Hereby, an azide building block reacts first with an ethynylphosphonite via the Staudinger‐phosphonite reaction (SPhR) to an ethynylphosphonamidate. The resulting electron‐deficient triple bond subsequently undergoes a cysteine‐selective reaction with proteins or antibodies. We demonstrate that ethynylphosphonamidates hold excellent cysteine‐selective reactivity combined with a superior stability of the thiol adducts. This turns our technique into a versatile and powerful tool for the facile construction of stable, functional protein conjugates.
-
FLEXamers: A Double Tag for Universal Generation of Versatile Peptide-MHC Multimers
The Journal of Immunology
Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research, clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, reversible Streptamers, or dye-conjugated pMHC multimers are distinct pMHC reagents tailored for T cell identification, traceless T cell isolation, or TCR characterization, respectively. The specific applicability of each pMHC-based reagent is made possible either through conjugation of probes or reversible multimerization…
Peptide-MHC (pMHC) multimers have become a valuable tool for immunological research, clinical immune monitoring, and immunotherapeutic applications. Biotinylated tetramers, reversible Streptamers, or dye-conjugated pMHC multimers are distinct pMHC reagents tailored for T cell identification, traceless T cell isolation, or TCR characterization, respectively. The specific applicability of each pMHC-based reagent is made possible either through conjugation of probes or reversible multimerization in separate production processes, which is laborious, time-consuming, and prone to variability between the different types of pMHC reagents. This prohibits broad implementation of different types of pMHC reagents as a standard toolbox in routine clinical immune monitoring and immunotherapy. In this article, we describe a novel method for fast and standardized generation of any pMHC multimer reagent from a single precursor (“FLEXamer”). FLEXamers unite reversible multimerization and versatile probe conjugation through a novel double tag (Strep-tag for reversibility and Tub-tag for versatile probe conjugation). We demonstrate that FLEXamers can substitute conventional pMHC reagents in all state-of-the-art applications, considerably accelerating and standardizing production without sacrificing functional performance. Although FLEXamers significantly aid the applicability of pMHC-based reagents in routine workflows, the double tag also provides a universal tool for the investigation of transient molecular interactions in general.
-
Chemical functionalization strategies and intracellular applications of nanobodies
Angew. Chem. Int. Ed.
Nanobodies can be considered as next-generation life science tools for the recognition and modulation of antigens that are inaccessible to conventional antibodies. Due to their compact structure and high stability, nanobodies see frequent usage in basic research. Their chemical functionalization facilitates powerful diagnostic tools and opens the way towards promising therapeutic applications. In this review, central aspects of nanobody functionalization are given together with selected…
Nanobodies can be considered as next-generation life science tools for the recognition and modulation of antigens that are inaccessible to conventional antibodies. Due to their compact structure and high stability, nanobodies see frequent usage in basic research. Their chemical functionalization facilitates powerful diagnostic tools and opens the way towards promising therapeutic applications. In this review, central aspects of nanobody functionalization are given together with selected applications in molecular cell biology. While first-generation conjugation strategies rely on random modification of natural amino acids, more recent studies focus on a site-specific attachment of functional groups. Such techniques include chemoenzymatic approaches, expressed protein ligation and amber suppression in combination with bioorthogonal modification strategies. With an ever growing toolkit of protein synthesis and conjugation, functional applications are on the rise as well. Such recent applications range from sophisticated imaging and mass spectrometry to the delivery of nanobodies into living cells, enabling visualization and manipulation of intracellular antigens.
-
Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells
Nature Chemistry
Functional antibody delivery in living cells would enable the labelling and manipulation of intracellular antigens, which constitutes a long-thought goal in cell biology and medicine. Here we present a modular strategy to create functional cell-permeable nanobodies capable of targeted labelling and manipulation of intracellular antigens in living cells. The cell-permeable nanobodies are formed by the site-specific attachment of intracellularly stable (or cleavable) cyclic arginine-rich…
Functional antibody delivery in living cells would enable the labelling and manipulation of intracellular antigens, which constitutes a long-thought goal in cell biology and medicine. Here we present a modular strategy to create functional cell-permeable nanobodies capable of targeted labelling and manipulation of intracellular antigens in living cells. The cell-permeable nanobodies are formed by the site-specific attachment of intracellularly stable (or cleavable) cyclic arginine-rich cell-penetrating peptides to camelid-derived single-chain VHH antibody fragments. We used this strategy for the non-endocytic delivery of two recombinant nanobodies into living cells, which enabled the relocalization of the polymerase clamp PCNA (proliferating cell nuclear antigen) and tumour suppressor p53 to the nucleolus, and thereby allowed the detection of protein–protein interactions that involve these two proteins in living cells. Furthermore, cell-permeable nanobodies permitted the co-transport of therapeutically relevant proteins, such as Mecp2, into the cells. This technology constitutes a major step in the labelling, delivery and targeted manipulation of intracellular antigens. Ultimately, this approach opens the door towards immunostaining in living cells and the expansion of immunotherapies to intracellular antigen targets.
-
Broad substrate tolerance of tubulin tyrosine ligase enables one-step site-specific enzymatic protein labeling
Chemical Science
The broad substrate tolerance of tubulin tyrosine ligase is the basic rationale behind its wide applicability for chemoenzymatic protein functionalization. In this context, we report that the wild-type enzyme enables ligation of various unnatural amino acids that are substantially bigger than and structurally unrelated to the natural substrate, tyrosine, without the need for extensive protein engineering. This unusual substrate flexibility is due to the fact that the enzyme's catalytic pocket…
The broad substrate tolerance of tubulin tyrosine ligase is the basic rationale behind its wide applicability for chemoenzymatic protein functionalization. In this context, we report that the wild-type enzyme enables ligation of various unnatural amino acids that are substantially bigger than and structurally unrelated to the natural substrate, tyrosine, without the need for extensive protein engineering. This unusual substrate flexibility is due to the fact that the enzyme's catalytic pocket forms an extended cavity during ligation, as confirmed by docking experiments and all-atom molecular dynamics simulations. This feature enabled one-step C-terminal biotinylation and fluorescent coumarin labeling of various functional proteins as demonstrated with ubiquitin, an antigen binding nanobody, and the apoptosis marker Annexin V. Its broad substrate tolerance establishes tubulin tyrosine ligase as a powerful tool for in vitro enzyme-mediated protein modification with single functional amino acids in a specific structural context.
Andere Autor:innenVeröffentlichung anzeigen -
Fusion to hydrophobin HFBI improves the catalytic performance of a cytochrome P450 system
Frontiers of Bioengineering and Biotechnology
-
Current Status: Site-Specific Antibody Drug Conjugates
Journal of Clinical Immunology
Antibody drug conjugates (ADCs), a promising class of cancer biopharmaceuticals, combine the specificity of therapeutic antibodies with the pharmacological potency of chemical, cytotoxic drugs. Ever since the first ADCs on the market, a plethora of novel ADC technologies has emerged, covering as diverse aspects as antibody engineering, chemical linker optimization and novel conjugation strategies, together aiming at constantly widening the therapeutic window for ADCs. This review primarily…
Antibody drug conjugates (ADCs), a promising class of cancer biopharmaceuticals, combine the specificity of therapeutic antibodies with the pharmacological potency of chemical, cytotoxic drugs. Ever since the first ADCs on the market, a plethora of novel ADC technologies has emerged, covering as diverse aspects as antibody engineering, chemical linker optimization and novel conjugation strategies, together aiming at constantly widening the therapeutic window for ADCs. This review primarily focuses on novel chemical and biotechnological strategies for the site-directed attachment of drugs that are currently validated for 2nd generation ADCs to promote conjugate homogeneity and overall stability.
Andere Autor:innenVeröffentlichung anzeigen -
Versatile and Efficient Site-Specific Protein Functionalization by Tubulin Tyrosine Ligase
Angewandte Chemie International Edition
A novel chemoenzymatic approach for simple and fast site-specific protein labeling is reported. Recombinant tubulin tyrosine ligase (TTL) was repurposed to attach various unnatural tyrosine derivatives as small bioorthogonal handles to proteins containing a short tubulin-derived recognition sequence (Tub-tag). This novel strategy enables a broad range of high-yielding and fast chemoselective C-terminal protein modifications on isolated proteins or in cell lysates for applications in…
A novel chemoenzymatic approach for simple and fast site-specific protein labeling is reported. Recombinant tubulin tyrosine ligase (TTL) was repurposed to attach various unnatural tyrosine derivatives as small bioorthogonal handles to proteins containing a short tubulin-derived recognition sequence (Tub-tag). This novel strategy enables a broad range of high-yielding and fast chemoselective C-terminal protein modifications on isolated proteins or in cell lysates for applications in biochemistry, cell biology, and beyond, as demonstrated by the site-specific labeling of nanobodies, GFP, and ubiquitin.
Andere Autor:innenVeröffentlichung anzeigen -
Total Synthesis of Solandelactones A and B
European Journal of Organic Chemistry
The total synthesis of solandelactones A and B is presented. The eastern cyclopropyl moiety was prepared following an exceptionally short chemoenzymatic approach whereas enantioselective synthesis of the western side-chain relied on the application of diastereomerically pure allyl boronates. The natural products solandelactones A and B were isolated in good overall yields following convergence of each eastern and western element by application of the Nozaki–Hiyama–Kishi reaction.
Andere Autor:innen -
More than add-on: chemoselective reactions for the synthesis of functional peptides and proteins
Current Opinion in Chemical Biology
The quest to enlarge the molecular space of functional biomolecules has led to the discovery of selective, mild and high-yielding chemical reactions for the modification of peptides and proteins. These conjugation methods have recently become even more advanced with the advent of modern biochemical techniques such as unnatural protein expression or enzymatic reactions that allow the site-specific modification of proteins.
Within this overview, we will highlight recent examples that…The quest to enlarge the molecular space of functional biomolecules has led to the discovery of selective, mild and high-yielding chemical reactions for the modification of peptides and proteins. These conjugation methods have recently become even more advanced with the advent of modern biochemical techniques such as unnatural protein expression or enzymatic reactions that allow the site-specific modification of proteins.
Within this overview, we will highlight recent examples that describe the site-specific functionalization of proteins. These examples go beyond the straightforward attachment of a given functional moiety to the protein backbone by employing either an innovative linker-design or by novel conjugation chemistry, where the modification reaction itself is responsible for the (altered) functional behaviour of the biomolecule. The examples covered herein include ‘turn-on’ probes for cellular imaging with low levels of background fluorescence, branched or cleavable polymer–protein conjugates of high stability within a cellular environment, the installation of natural occurring posttranslational modifications to help understand their role in complex cellular environments and finally the engineering of novel antibody drug conjugates to facilitate target specific drug release.Andere Autor:innen
Kurse
-
Academic writing
-
-
Career planning
-
-
Fallstudienkurs Controlling
-
-
Team & Führungskompetenz in der Wissenschaft und außerhalb
-
Auszeichnungen/Preise
-
MIT Tech Review Innovator under 35 Europe 2018
MIT Technology Review
Since its creation, MIT Technology Review has been publishing the list of the most brilliant Innovators Under 35 that are making exciting strides, shaping their fields and solving problems in remarkably different ways.
The Innovators Under 35 Europe 2018 have been selected by the jury from more than 1,000 candidates. Among the winners there are different profiles, from researchers to entrepreneurs, and all are developing new projects that will change all areas of society and business…Since its creation, MIT Technology Review has been publishing the list of the most brilliant Innovators Under 35 that are making exciting strides, shaping their fields and solving problems in remarkably different ways.
The Innovators Under 35 Europe 2018 have been selected by the jury from more than 1,000 candidates. Among the winners there are different profiles, from researchers to entrepreneurs, and all are developing new projects that will change all areas of society and business, as well as our ways of working, learning, curing, manufacturing or communicating. The 35 innovators will be awarded in the different categories of the competition: entrepreneurs, humanitarian, pioneers, visionaries, and inventors.
https://www.innovatorsunder35.com/regions/europe/ -
Schering Prize
Schering Foundation
The Schering Prize is valued at 5,000 euro and awarded annually by the Schering Stiftung. Since 2009 the three universities of Berlin may nominate candidates for the award that honors the best dissertation in the field of chemistry. Before is was awarded in cooperation with the Society of Friends of the Technical University of Berlin for the best dissertation in the field of chemistry at the Technical University of Berlin. The prize was awarded for the first time in…
The Schering Prize is valued at 5,000 euro and awarded annually by the Schering Stiftung. Since 2009 the three universities of Berlin may nominate candidates for the award that honors the best dissertation in the field of chemistry. Before is was awarded in cooperation with the Society of Friends of the Technical University of Berlin for the best dissertation in the field of chemistry at the Technical University of Berlin. The prize was awarded for the first time in 1986.
https://scheringstiftung.de/en/programm/lebenswissenschaften/preise/schering-preis/schering-preis-2017/ -
Rainer Rudolph Prize
Rainer Rudolph Foundation
The Rainer Rudolph Foundation awards outstanding graduation works and scientific contributions to the field of protein biochemistry and biotechnology.
https://www.rainer-rudolph-stiftung.de/de/foerderung/Preistraeger -
Top Innovator under 35 - Germany
Technology Review (Heise)
https://www.heise.de/tr/artikel/Die-Morgen-Macher-4084941.html?seite=all
-
Leibniz Entrepreneur Award 2018
Leibniz Association
The Leibniz Association honored the start-up Tubulis Technologies with the Leibniz Entrepreneur Award 2018. The entrepreneurs are well on their way to providing targeted chemotherapeutic agents with fewer side effects. The prize is endowed with EUR 50,000 for the further development of the entrepreneurial concept.
-
Gold-Medal
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
Award for outstanding scientific contributions
-
BioRiver Boost! 2017 Award
BioRiver Life Science im Reihnland e.V.
-
Science4Life Venture Cup (BP competition)
-
Winner of Idea, Concept and BusinessPlan Phase (Tubulis Technologies)
-
Winner of EIT Health LaunchLab Program
EIT Health
-
Audience Award Science Slam
Long Night of Science 2016 - MDC
-
Renewal Kekulé Scholarship
Verband der Chemischen Industrie
-
APS2015 Travel Grant
American Peptide Society
-
Best Poster Award
GDCh Bioorthogonal Chemistry Meeting
-
Keklué Scholarship
Verband der Chemischen Industrie
-
NRW Scholarship
Heinrich Heine Universität / NRW
-
Deutschlandstipendium Chancen Nutzen
Heinrich Heine Universität / NRW
-
GDCh Abiturientenpreis for best Abitur in Chemistry
GDCh
Organisationen
-
American Chemical Society
-
–Heute -
Gesellschaft Deutscher Chemiker
-
–Heute -
Gemeinschaft Düsseldorfer Wirtschaftschemiker
-
–Heute -
Rotaract - Partner of Rotary
-
–Heute
Weitere Aktivitäten von Dominik Schumacher
-
Dr. Alexander Schueller is one of the founders and CEO of cellvie, a company developing therapeutic interventions using mitochondria transplantation.…
Dr. Alexander Schueller is one of the founders and CEO of cellvie, a company developing therapeutic interventions using mitochondria transplantation.…
Beliebt bei Dominik Schumacher
-
After an incredible journey, I’ll be stepping down from my role on the Management Board of Evotec at the end of this month. I'm deeply grateful for…
After an incredible journey, I’ll be stepping down from my role on the Management Board of Evotec at the end of this month. I'm deeply grateful for…
Beliebt bei Dominik Schumacher
-
Meet our team at Morgan Stanley’s 22nd Annual Global #Healthcare Conference from September 4-6 in #NYC! Our CEO, Dominik Schumacher, our CBO, Ingo…
Meet our team at Morgan Stanley’s 22nd Annual Global #Healthcare Conference from September 4-6 in #NYC! Our CEO, Dominik Schumacher, our CBO, Ingo…
Beliebt bei Dominik Schumacher
-
“Every new beginning comes from some other beginning's end” After 7 incredible years at #bayer, today marks my last working day. It’s been a journey…
“Every new beginning comes from some other beginning's end” After 7 incredible years at #bayer, today marks my last working day. It’s been a journey…
Beliebt bei Dominik Schumacher
-
Europäische Unternehmen, die Fleisch- und Milchalternativen auf Basis von Pflanzen, Fermentation und Zellkulturen herstellen, konnten im ersten…
Europäische Unternehmen, die Fleisch- und Milchalternativen auf Basis von Pflanzen, Fermentation und Zellkulturen herstellen, konnten im ersten…
Beliebt bei Dominik Schumacher
-
An innovative platform for tailor-made #antibodydrugconjugates (#ADCs) enbaling less invasive and more efficient #cancer treatments: 🔈„Our goal…
An innovative platform for tailor-made #antibodydrugconjugates (#ADCs) enbaling less invasive and more efficient #cancer treatments: 🔈„Our goal…
Beliebt bei Dominik Schumacher
-
#ICYMI: Last month, Clarivate for Life Sciences & Healthcare featured us as 1 of 7 “Companies to Watch” in the #ADC space, highlighting our…
#ICYMI: Last month, Clarivate for Life Sciences & Healthcare featured us as 1 of 7 “Companies to Watch” in the #ADC space, highlighting our…
Beliebt bei Dominik Schumacher
-
Invest in the future of Healthcare, invest in Pirche, a portfolio company of Science Holding Upcoming webinar on August 13, 2024, 5:30 PM CET The…
Invest in the future of Healthcare, invest in Pirche, a portfolio company of Science Holding Upcoming webinar on August 13, 2024, 5:30 PM CET The…
Geteilt von Dominik Schumacher
-
𝗧𝗲𝗮𝗺 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: 𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀! Positive questions are key to bringing more positivity…
𝗧𝗲𝗮𝗺 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: 𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀! Positive questions are key to bringing more positivity…
Beliebt bei Dominik Schumacher
-
We're excited to have been selected for a presentation at BioCentury's Grand Rounds 2024: Engaging Thought Leaders at the Academia/Industry…
We're excited to have been selected for a presentation at BioCentury's Grand Rounds 2024: Engaging Thought Leaders at the Academia/Industry…
Beliebt bei Dominik Schumacher
-
Tubulis is selected as one of Fierce Biotech's 2024 #Fierce15 #biotech companies! What an amazing recognition for our Tubulis GmbH #TEAM and our…
Tubulis is selected as one of Fierce Biotech's 2024 #Fierce15 #biotech companies! What an amazing recognition for our Tubulis GmbH #TEAM and our…
Geteilt von Dominik Schumacher
Weitere ähnliche Profile
Weitere Mitglieder namens Dominik Schumacher in Deutschland
-
Dominik Schumacher
IT-Fachausbilder beim IT-Systemhaus der Bundesagentur für Arbeit | #GernePerDu
-
Dominik Schumacher
-
Dominik Schumacher
Digital Artist
-
Dominik Schumacher
Leiter Ersatzteilvertrieb bei Masa Group
Es gibt auf LinkedIn 13 weitere Personen namens Dominik Schumacher, die sich in Deutschland befinden.
Weitere Mitglieder anzeigen, die Dominik Schumacher heißen